Literature DB >> 23768642

Pathobiology of T-cell and NK-cell lymphomas.

Ewa B Bajor-Dattilo1, Stefania Pittaluga, Elaine S Jaffe.   

Abstract

T-cell and NK-cell lymphomas are uncommon lymphomas with an aggressive clinical course. The causes and precise cellular origins of most T-cell lymphomas are still not well defined. The WHO classification utilizes morphologic and immunophenotypic features in conjunction with clinical aspects and in some instances genetics to delineate a prognostically and therapeutically meaningful categorization. The anatomic localization of neoplastic T-cells and NK-cells parallels in part their proposed normal cellular counterparts and functions. T-cells of the adaptive immune system are mainly based in lymph nodes and peripheral blood, whereas lymphomas derived from T-cells and NK-cells of the innate immune system are mainly extranodal. This approach allows for better understanding of some of the manifestations of the T-cell and NK-cell lymphomas, including their cellular distribution, some aspects of morphology and even associated clinical findings. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23768642      PMCID: PMC3718892          DOI: 10.1016/j.beha.2013.04.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


  92 in total

1.  Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.

Authors:  S Kumar; L Krenacs; J Medeiros; K S Elenitoba-Johnson; T C Greiner; L Sorbara; D W Kingma; M Raffeld; E S Jaffe
Journal:  Hum Pathol       Date:  1998-04       Impact factor: 3.466

2.  Proteomic analysis of mantle-cell lymphoma by protein microarray.

Authors:  Irene M Ghobrial; Daniel J McCormick; Scott H Kaufmann; Alexey A Leontovich; David A Loegering; Nga T Dai; Kelly L Krajnik; Mary J Stenson; Mona F Melhem; Anne J Novak; Stephen M Ansell; Thomas E Witzig
Journal:  Blood       Date:  2005-01-13       Impact factor: 22.113

3.  ALK+ lymphoma: clinico-pathological findings and outcome.

Authors:  B Falini; S Pileri; P L Zinzani; A Carbone; V Zagonel; C Wolf-Peeters; G Verhoef; F Menestrina; G Todeschini; M Paulli; M Lazzarino; R Giardini; A Aiello; H D Foss; I Araujo; M Fizzotti; P G Pelicci; L Flenghi; M F Martelli; A Santucci
Journal:  Blood       Date:  1999-04-15       Impact factor: 22.113

4.  Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infection.

Authors:  L Quintanilla-Martinez; F Fend; L R Moguel; L Spilove; M W Beaty; D W Kingma; M Raffeld; E S Jaffe
Journal:  Am J Surg Pathol       Date:  1999-10       Impact factor: 6.394

5.  Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin.

Authors:  C B Cooke; L Krenacs; M Stetler-Stevenson; T C Greiner; M Raffeld; D W Kingma; L Abruzzo; C Frantz; M Kaviani; E S Jaffe
Journal:  Blood       Date:  1996-12-01       Impact factor: 22.113

Review 6.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

7.  B-cell lymphoma after angioimmunoblastic lymphadenopathy: a case with oligoclonal gene rearrangements associated with Epstein-Barr virus.

Authors:  L V Abruzzo; K Schmidt; L M Weiss; E S Jaffe; L J Medeiros; C A Sander; M Raffeld
Journal:  Blood       Date:  1993-07-01       Impact factor: 22.113

8.  Bone marrow involvement in anaplastic large cell lymphoma. Immunohistochemical detection of minimal disease and its prognostic significance.

Authors:  M Fraga; P Brousset; D Schlaifer; C Payen; A Robert; H Rubie; F Huguet-Rigal; G Delsol
Journal:  Am J Clin Pathol       Date:  1995-01       Impact factor: 2.493

9.  Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes.

Authors:  K E Salhany; W R Macon; J K Choi; R Elenitsas; S R Lessin; R E Felgar; D M Wilson; G K Przybylski; J Lister; M A Wasik; S H Swerdlow
Journal:  Am J Surg Pathol       Date:  1998-07       Impact factor: 6.394

10.  Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling.

Authors:  Irina Bonzheim; Eva Geissinger; Sabine Roth; Andreas Zettl; Alexander Marx; Andreas Rosenwald; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  Blood       Date:  2004-08-05       Impact factor: 22.113

View more
  8 in total

1.  Mutations in 5-methylcytosine oxidase TET2 and RhoA cooperatively disrupt T cell homeostasis.

Authors:  Shengbing Zang; Jia Li; Haiyan Yang; Hongxiang Zeng; Wei Han; Jixiang Zhang; Minjung Lee; Margie Moczygemba; Sevinj Isgandarova; Yaling Yang; Yubin Zhou; Anjana Rao; M James You; Deqiang Sun; Yun Huang
Journal:  J Clin Invest       Date:  2017-07-10       Impact factor: 14.808

Review 2.  Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.

Authors:  Manli Jiang; N Nora Bennani; Andrew L Feldman
Journal:  Expert Rev Hematol       Date:  2017-01-29       Impact factor: 2.929

3.  Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma.

Authors:  Ziwei Liao; Lingling Zhou; Chunyan Wang; Zhifeng He; Xu Wang; Xiaodan Luo; Shaohua Chen; Lijian Yang; Huo Tan; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2014-12-16       Impact factor: 3.311

4.  Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System.

Authors:  Haneen Shalabi; Anne Angiolillo; Gilbert Vezina; James L Rubenstein; Stefania Pittaluga; Mark Raffeld; Leigh Marcus
Journal:  Pediatr Hematol Oncol       Date:  2015-09-18       Impact factor: 1.969

5.  A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP.

Authors:  Matthew S J Mangan; Catherina H Bird; Dion Kaiserman; Anthony Y Matthews; Corinne Hitchen; David L Steer; Philip E Thompson; Phillip I Bird
Journal:  J Biol Chem       Date:  2015-12-15       Impact factor: 5.157

Review 6.  T-cell lymphomas, a challenging disease: types, treatments, and future.

Authors:  Helen Ma; Maher Abdul-Hay
Journal:  Int J Clin Oncol       Date:  2016-10-14       Impact factor: 3.402

7.  Early diagnosis of an isolated primary peripheral T-cell lymphoma masquerading as massive gingival enlargement in a pediatric patient.

Authors:  Sravani Ghattamaneni; Venkateswara Rao Guttikonda; Sivaranjani Yeluri; Rajani Kolipara
Journal:  J Oral Maxillofac Pathol       Date:  2017 Sep-Dec

8.  Clinical analysis of 42 cases of EBV-positive mature T/NK-cell neoplasms.

Authors:  Haiyan Yang; Gan Fu; Jia Liu; Zhenzhen Da; Xiaoye Cheng; Cong Chen; Yan Li; Bin Fu; Xiaolin Li
Journal:  Exp Ther Med       Date:  2017-06-01       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.